Actively Recruiting
NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer
Led by Aarhus University Hospital · Updated on 2024-08-14
400
Participants Needed
13
Research Sites
408 weeks
Total Duration
On this page
Sponsors
A
Aarhus University Hospital
Lead Sponsor
D
Danish Comprehensive Cancer Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study investigates if circulating tumor DNA can improve the detection of early treatment failure or recurrence in localized squamous cell carcinoma of the anus (SCCA) after curative chemoradiotherapy thereby increasing the potential for cure. This will be done by comparing the standard follow-up program with ctDNA guided imaging follow-up. Secondly, the aim is to establish early interventions against late morbidities.
CONDITIONS
Official Title
NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with squamous cell carcinoma of the anus eligible for definitive chemoradiotherapy
- 18 years of age or older
- Written and oral consent given
You will not qualify if you...
- Conditions that prevent blood samples from being taken
- Conditions that prevent a PET-CT scan
- Potential lack of compliance with standard follow-up program and study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 13 locations
1
Department of Oncology Herlev and Gentofte Hospital
Herlev, Capital Region of Denmark, Denmark, 2730
Actively Recruiting
2
Department of Oncology, Vejle Hospital
Vejle, The Regions of Southern Denmark, Denmark, 7100
Actively Recruiting
3
Aarhus University Hospital
Aarhus, Denmark, 8000
Actively Recruiting
4
Tampere University Hospital
Tampere, Finland, 33520
Not Yet Recruiting
5
Turku University Hospital
Turku, Finland, 20521
Not Yet Recruiting
6
Haukeland University Hospital
Bergen, Norway, 5021
Not Yet Recruiting
7
Oslo University Hospital
Oslo, Norway, 0450
Not Yet Recruiting
8
University Hospital of North Norway
Tromsø, Norway, 9019
Not Yet Recruiting
9
St. Olav's University Hospital
Trondheim, Norway, 7030
Not Yet Recruiting
10
Sahlgrenska University Hospital
Gothenburg, Sweden, 413 45
Not Yet Recruiting
11
Skåne University Hospital Lund
Lund, Sweden, 222 42
Not Yet Recruiting
12
Karonlinska University Hospital
Stockholm, Sweden, 171 64
Not Yet Recruiting
13
Norrlands University Hospital
Umeå, Sweden, 907 37
Not Yet Recruiting
Research Team
K
Karen-Lise G Spindler, Professor
CONTACT
L
Louise V Laursen, Secretary
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here